SK18962000A3 - Tetrahydronaftyridinylkarboxamidové zlúčeniny, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie - Google Patents
Tetrahydronaftyridinylkarboxamidové zlúčeniny, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie Download PDFInfo
- Publication number
- SK18962000A3 SK18962000A3 SK1896-2000A SK18962000A SK18962000A3 SK 18962000 A3 SK18962000 A3 SK 18962000A3 SK 18962000 A SK18962000 A SK 18962000A SK 18962000 A3 SK18962000 A3 SK 18962000A3
- Authority
- SK
- Slovakia
- Prior art keywords
- tetrahydro
- naphthyridin
- trimethyl
- alkyl
- disorders
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Psychology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9812683.2A GB9812683D0 (en) | 1998-06-12 | 1998-06-12 | Novel compounds |
| PCT/GB1999/001826 WO1999065903A1 (en) | 1998-06-12 | 1999-06-09 | Tetrahydronaphthyridinyl-carboxamides having anti-convulsant activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK18962000A3 true SK18962000A3 (sk) | 2001-08-06 |
Family
ID=10833636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1896-2000A SK18962000A3 (sk) | 1998-06-12 | 1999-06-09 | Tetrahydronaftyridinylkarboxamidové zlúčeniny, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie |
Country Status (31)
| Country | Link |
|---|---|
| US (2) | US6410555B1 (es) |
| EP (1) | EP1084122B1 (es) |
| JP (1) | JP2002518390A (es) |
| KR (1) | KR20010052792A (es) |
| CN (1) | CN1311789A (es) |
| AP (1) | AP2000002009A0 (es) |
| AR (1) | AR018656A1 (es) |
| AT (1) | ATE252579T1 (es) |
| AU (1) | AU750470B2 (es) |
| BG (1) | BG105126A (es) |
| BR (1) | BR9911110A (es) |
| CA (1) | CA2334900A1 (es) |
| CO (1) | CO5040081A1 (es) |
| CZ (1) | CZ293010B6 (es) |
| DE (1) | DE69912278T2 (es) |
| EA (1) | EA200100033A1 (es) |
| ES (1) | ES2209524T3 (es) |
| GB (1) | GB9812683D0 (es) |
| HU (1) | HUP0102773A3 (es) |
| ID (1) | ID27593A (es) |
| IL (1) | IL140171A0 (es) |
| MA (1) | MA26646A1 (es) |
| NO (1) | NO20006269L (es) |
| NZ (1) | NZ508799A (es) |
| PE (1) | PE20000727A1 (es) |
| PL (1) | PL344791A1 (es) |
| SK (1) | SK18962000A3 (es) |
| TR (1) | TR200003694T2 (es) |
| TW (1) | TW495510B (es) |
| WO (1) | WO1999065903A1 (es) |
| ZA (1) | ZA200007397B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9812683D0 (en) * | 1998-06-12 | 1998-08-12 | Smithkline Beecham Plc | Novel compounds |
| DE60100055T2 (de) * | 2001-03-21 | 2003-07-24 | Sanol Arznei Schwarz Gmbh | Neue Verwendung einer Klasse von Peptidverbindungen zur Behandlung von Allodynie oder andere Arten von chronischen oder Phantomschmerzen |
| EP1945639A1 (en) * | 2005-11-04 | 2008-07-23 | Pfizer Limited | Tetrahydronaphthyridine derivative |
| WO2014036015A1 (en) * | 2012-08-27 | 2014-03-06 | Array Biopharma Inc. | Serine/threonine kinase inhibitors for the treatment of hyperproliferative|diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9112721D0 (en) | 1991-06-13 | 1991-07-31 | Smithkline Beecham Plc | Novel treatment |
| AR008234A1 (es) * | 1996-06-17 | 1999-12-29 | Smithkline Beecham Plc | Derivados de benzamidas, procedimiento para su preparacion, composiciones farmaceuticas y su uso para la preparacion de un medicamento |
| GB9711257D0 (en) | 1997-05-30 | 1997-07-30 | Smithkline Beecham Plc | Novel compounds |
| GB9812683D0 (en) * | 1998-06-12 | 1998-08-12 | Smithkline Beecham Plc | Novel compounds |
-
1998
- 1998-06-12 GB GBGB9812683.2A patent/GB9812683D0/en not_active Ceased
-
1999
- 1999-06-09 CZ CZ20004611A patent/CZ293010B6/cs not_active IP Right Cessation
- 1999-06-09 AP APAP/P/2000/002009A patent/AP2000002009A0/en unknown
- 1999-06-09 JP JP2000554728A patent/JP2002518390A/ja active Pending
- 1999-06-09 KR KR1020007014099A patent/KR20010052792A/ko not_active Application Discontinuation
- 1999-06-09 DE DE69912278T patent/DE69912278T2/de not_active Expired - Fee Related
- 1999-06-09 SK SK1896-2000A patent/SK18962000A3/sk unknown
- 1999-06-09 AT AT99957056T patent/ATE252579T1/de not_active IP Right Cessation
- 1999-06-09 IL IL14017199A patent/IL140171A0/xx unknown
- 1999-06-09 ES ES99957056T patent/ES2209524T3/es not_active Expired - Lifetime
- 1999-06-09 ID IDW20002580A patent/ID27593A/id unknown
- 1999-06-09 PL PL99344791A patent/PL344791A1/xx not_active Application Discontinuation
- 1999-06-09 AU AU42800/99A patent/AU750470B2/en not_active Ceased
- 1999-06-09 WO PCT/GB1999/001826 patent/WO1999065903A1/en not_active Application Discontinuation
- 1999-06-09 EP EP99957056A patent/EP1084122B1/en not_active Expired - Lifetime
- 1999-06-09 CN CN99809413A patent/CN1311789A/zh active Pending
- 1999-06-09 HU HU0102773A patent/HUP0102773A3/hu unknown
- 1999-06-09 CA CA002334900A patent/CA2334900A1/en not_active Abandoned
- 1999-06-09 NZ NZ508799A patent/NZ508799A/en unknown
- 1999-06-09 BR BR9911110-1A patent/BR9911110A/pt not_active IP Right Cessation
- 1999-06-09 EA EA200100033A patent/EA200100033A1/ru unknown
- 1999-06-09 US US09/719,335 patent/US6410555B1/en not_active Expired - Fee Related
- 1999-06-09 TR TR2000/03694T patent/TR200003694T2/xx unknown
- 1999-06-10 AR ARP990102772A patent/AR018656A1/es not_active Application Discontinuation
- 1999-06-10 MA MA25618A patent/MA26646A1/fr unknown
- 1999-06-11 PE PE1999000519A patent/PE20000727A1/es not_active Application Discontinuation
- 1999-06-11 CO CO99036865A patent/CO5040081A1/es unknown
- 1999-06-11 TW TW088109749A patent/TW495510B/zh active
-
2000
- 2000-12-11 NO NO20006269A patent/NO20006269L/no not_active Application Discontinuation
- 2000-12-12 ZA ZA200007397A patent/ZA200007397B/xx unknown
-
2001
- 2001-01-08 BG BG105126A patent/BG105126A/xx unknown
-
2002
- 2002-05-23 US US10/154,997 patent/US6762192B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2944048B2 (ja) | 二環式テトラヒドロピラゾロピリジン | |
| KR100235277B1 (ko) | 피라졸로- 및 피롤로-피리딘 | |
| KR101216296B1 (ko) | 티에노피리디논 화합물 및 치료 방법 | |
| US20040044021A1 (en) | Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors | |
| US8952158B2 (en) | Tricyclic compound and use thereof | |
| JP2019513745A (ja) | ピロロ［１，２−ａ］ピリミジニルカルボキサミド化合物および医学的障害の処置におけるその使用 | |
| JP2012512192A (ja) | 皮膚疾患の処置のためのホスホジエステラーゼ阻害薬としてのトリアゾロピリジン誘導体 | |
| AU2010200563A1 (en) | Bicyclic amides for enhancing glutamatergic synaptic responses | |
| PL192116B1 (pl) | Pochodne izochinoliny, zawierająca je kompozycja farmaceutyczna oraz zastosowanie pochodnych izochinoliny | |
| US20040006079A1 (en) | Substituted 2,4-dihydro-pyrrolo[3,4-b]quinolin-9-one derivatives useful as phosphodiesterase inhibitors | |
| CZ416498A3 (cs) | Substituovaný benzamidový derivát a jeho použití jako antikonvulsantu | |
| SK9142000A3 (en) | Tetrahydro isoquinolinyl carboxamide compounds, preparation thereof, pharmaceutical composition containing them and their use | |
| JP2001518908A (ja) | ピリダジンおよびフタラジン誘導体、それらの製造方法および抗痙攣剤としてのそれらの使用 | |
| SK18962000A3 (sk) | Tetrahydronaftyridinylkarboxamidové zlúčeniny, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie | |
| SK126799A3 (en) | Isoquinolyl-benzamide derivatives, process for their production, pharmaceutical composition containing them and their use | |
| JP2001517668A (ja) | Ｎ−５，６，７，８−テトラヒドロ（１、６）ナフチリジン−ｎ’−フェニルウレア誘導体 | |
| JP2002522436A (ja) | 三環式カルボキシアミド類 | |
| JP2002501517A (ja) | １，６−ナフチリジン抗痙攣薬 | |
| CZ20014721A3 (cs) | Nové sloučeniny | |
| WO2019157014A1 (en) | N-methyl-d-aspartic acid receptor modulators | |
| JP2001519798A (ja) | 抗痙攣作用を有するピリミド−イソキノリン化合物 | |
| MXPA00012322A (es) | Tetrahidronaftiridinil-carboxamidas que tienen actividad anticonvulsiva | |
| CZ20002221A3 (cs) | Substituované deriváty isochinolinu a jejich použití jako antikonvulziva | |
| US20230355593A1 (en) | N-methyl-D-aspartic Acid Receptor Modulators | |
| AU2001261178A1 (en) | Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors |